Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1986 Sep;89(1):229–234. doi: 10.1111/j.1476-5381.1986.tb11139.x

Biphasic actions of L-DOPA on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices.

Y Goshima, T Kubo, Y Misu
PMCID: PMC1917033  PMID: 3801773

Abstract

Effects of L-DOPA on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices evoked by electrical field stimulation at 5 Hz were investigated in the absence and presence of p-bromobenzyloxyamine (NSD-1055), a DOPA-decarboxylase inhibitor. In the absence of NSD-1055, L-DOPA produced a facilitation of impulse-evoked release of noradrenaline at 0.1 microM but not at 1 and 10 microM, and had no effect on the spontaneous release. On the other hand, L-DOPA 0.1 to 10 microM dose-dependently increased the spontaneous release of dopamine and the highest concentration only increased the evoked release and tissue content of dopamine. In the presence of NSD-1055 10 microM, the increase in the spontaneous release of dopamine was prevented and L-DOPA produced biphasic regulatory effects on the evoked release of noradrenaline and dopamine, a facilitation at 0.1 microM and an inhibition at 1 microM. The facilitation was antagonized by (-)-propranolol 0.1 microM, but not by the (+)-isomer, whereas the inhibition was antagonized by S-sulpiride 1 nM, but not by the R-isomer. In conclusion, L-DOPA appears to produce biphasic actions on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices, not through its conversion to dopamine but through presynaptic regulatory mechanisms, an inhibition via dopamine receptors at a micromolar concentration and a facilitation via beta-adrenoceptors at the lower concentration.

Full text

PDF
229

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bunney B. S., Aghajanian G. K., Roth R. H. Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nat New Biol. 1973 Sep 26;245(143):123–125. doi: 10.1038/newbio245123a0. [DOI] [PubMed] [Google Scholar]
  2. Glowinski J., Iversen L. L. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem. 1966 Aug;13(8):655–669. doi: 10.1111/j.1471-4159.1966.tb09873.x. [DOI] [PubMed] [Google Scholar]
  3. Goshima Y., Kubo T., Misu Y. Autoregulation of endogenous epinephrine release via presynaptic adrenoceptors in the rat hypothalamic slice. J Pharmacol Exp Ther. 1985 Oct;235(1):248–253. [PubMed] [Google Scholar]
  4. Hirata Y., Togari A., Nagatsu T. Studies on tyrosine hydroxylase system in rat brain slices using high-performance liquid chromatography with electrochemical detection. J Neurochem. 1983 Jun;40(6):1585–1589. doi: 10.1111/j.1471-4159.1983.tb08130.x. [DOI] [PubMed] [Google Scholar]
  5. Kebabian J. W., Calne D. B. Multiple receptors for dopamine. Nature. 1979 Jan 11;277(5692):93–96. doi: 10.1038/277093a0. [DOI] [PubMed] [Google Scholar]
  6. Lloyd K. G., Davidson L., Hornykiewicz O. The neurochemistry of Parkinson's disease: effect of L-dopa therapy. J Pharmacol Exp Ther. 1975 Dec;195(3):453–464. [PubMed] [Google Scholar]
  7. Lokhandwala M. F., Buckley J. P. The effect of L-dopa on peripheral sympathetic nerve function: role of presynaptic dopamine receptors. J Pharmacol Exp Ther. 1978 Feb;204(2):362–371. [PubMed] [Google Scholar]
  8. Misu Y., Goshima Y., Ueda H., Kubo T. Presynaptic inhibitory dopamine receptors on noradrenergic nerve terminals: analysis of biphasic actions of dopamine and apomorphine on the release of endogenous norepinephrine in rat hypothalamic slices. J Pharmacol Exp Ther. 1985 Dec;235(3):771–777. [PubMed] [Google Scholar]
  9. Ng K. Y., Chase T. N., Colburn R. W., Kopin I. J. Dopamine: stimulation-induced release from central neurons. Science. 1971 Apr 30;172(3982):487–489. doi: 10.1126/science.172.3982.487. [DOI] [PubMed] [Google Scholar]
  10. Ng K. Y., Chase T. N., Colburn R. W., Kopin I. J. L-Dopa-induced release of cerebral monoamines. Science. 1970 Oct 2;170(3953):76–77. doi: 10.1126/science.170.3953.76. [DOI] [PubMed] [Google Scholar]
  11. Ponzio F., Achilli G., Perego C., Rinaldi G., Algeri S. Does acute L-DOPA increase active release of dopamine from dopaminergic neurons? Brain Res. 1983 Aug 22;273(1):45–51. doi: 10.1016/0006-8993(83)91092-2. [DOI] [PubMed] [Google Scholar]
  12. Ueda H., Goshima Y., Kubo T., Misu Y. Adrenaline involvement in the presynaptic beta-adrenoceptor-mediated mechanism of dopamine release from slices of the rat hypothalamus. Life Sci. 1984 Mar 12;34(11):1087–1093. doi: 10.1016/0024-3205(84)90022-5. [DOI] [PubMed] [Google Scholar]
  13. Ueda H., Goshima Y., Kubo T., Misu Y. Involvement of epinephrine in the presynaptic beta adrenoceptor mechanism of norepinephrine release from rat hypothalamic slices. J Pharmacol Exp Ther. 1985 Feb;232(2):507–512. [PubMed] [Google Scholar]
  14. Ueda H., Goshima Y., Misu Y. Presynaptic alpha 2- and dopamine-receptor-mediated inhibitory mechanisms and dopamine nerve terminals in the rat hypothalamus. Neurosci Lett. 1983 Sep 30;40(2):157–162. doi: 10.1016/0304-3940(83)90295-1. [DOI] [PubMed] [Google Scholar]
  15. Ueda H., Goshima Y., Misu Y. Presynaptic mediation by alpha 2-, beta 1- and beta 2-adrenoceptors of endogenous noradrenaline and dopamine release from slices of rat hypothalamus. Life Sci. 1983 Jul 25;33(4):371–376. doi: 10.1016/s0024-3205(83)80011-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES